Article: InvestSource: CepTor Finds Validation in the New England Journal of Medicine.

M2 PRESSWIRE-6 July 2005-InvestSource Inc.: InvestSource: CepTor Finds Validation in the New England Journal of Medicine(C)1994-2005 M2 COMMUNICATIONS LTD

RDATE:06072005

Stocks in the News: CepTor Corporation (Other OTC: CEPO), Omnicare Incorporated (NYSE: OCR), Armor Holdings Incorporated (NYSE: AH), Bausch & Lomb Incorporated (NYSE: BOL)

CepTor Corporation (Other OTC: CEPO) CEO William Pursley discussed recent events on the following webcast this past Monday, June 27. Among the items discusses was the June 9th article in the New England Journal of Medicine, "Mechanisms of Disease: Calpains and Disease." The article substantiates CepTor's drug ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!